Product NewsImmunovaccine Reports Promising Clinical Activity for Novel T Cell Activating Immunotherapy DPX-Survivac at ASCO 2014
Industry NewsImmunovaccine and NCIC Clinical Trials Group To Collaborate on Phase II Study of DPX-Survivac
